Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT01379612 | Ultrasound Elastography in Patients With Rectal Cancer | completed | — | 31 | Vejle HospitalOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00677443 |
| Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer |
| completed |
| Phase 3 |
| 344 |
| Samsung Medical CenterOTHER |
| 1 |
| Jun 14, 2013 |
| clinicaltrials |
| NCT00743678 | Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis | completed | Phase 2 | 73 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT01281761 | Simvastatin + Cetuximab/Irinotecan in K-ras Mutant Colorectal Cancer (CRC) | completed | Phase 2 | 52 | Samsung Medical CenterOTHER | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00081237 | OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer | completed | Phase 1 | 15 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jun 12, 2013 | clinicaltrials |
| NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 16 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jun 12, 2013 | clinicaltrials |
| NCT00433602 | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | completed | — | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT01026753 | Innovative Tools to Improve Colorectal Cancer Screening Rates in Manitoba | completed | N/A | 2,395 | University of ManitobaOTHER | 1 | Jun 11, 2013 | clinicaltrials |
| NCT01322152 | Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer | completed | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Jun 11, 2013 | clinicaltrials |
| NCT00027729 | Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00028626 | Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | completed | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01301417 | Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis(RETROPRESS) | completed | — | 171 | novoGIINDUSTRY | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00220051 | A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer | completed | Phase 2 | 109 | Royal Marsden NHS Foundation TrustOTHER | 0 | May 31, 2013 | clinicaltrials |
| NCT00220142 | Molecular Markers of Prognosis in Colorectal Cancer Patients | completed | — | 103 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 31, 2013 | clinicaltrials |
| NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | completed | Phase 1 / Phase 2 | — | IntracelINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01289288 | A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese(CRC) | completed | Phase 1 / Phase 2 | 480 | Georgetown UniversityOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT00560560 | Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments | completed | Phase 2 | 168 | PfizerINDUSTRY | 3 | May 20, 2013 | clinicaltrials |
| NCT00785122 | IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)(IMA910-101) | completed | Phase 1 / Phase 2 | 92 | Immatics Biotechnologies GmbHINDUSTRY | 9 | May 16, 2013 | clinicaltrials |
| NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | completed | Phase 2 | 159 | AbbVie (prior sponsor, Abbott)INDUSTRY | 14 | May 15, 2013 | clinicaltrials |
| NCT00111774 | Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma | completed | Phase 2 | 150 | AmgenINDUSTRY | 0 | May 14, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00780169 | Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer | completed | Phase 1 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT00855946 | Proteomic Approach Using Matrix-assisted Laser Desorption/Ionization Tandem Time-of-flight (MALDI-TOF/TOF) of Tumor Response in Rectal Carcinoma After Radiochemotherapy(PROTEORECTUM) | completed | — | 46 | University Hospital, BordeauxOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00290615 | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 30 | Herbert HurwitzOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00005036 | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 3 | 560 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01341366 | Fast-track Perioperative Program for Laparoscopic Colorectal Surgery | completed | Phase 3 | 128 | Chinese University of Hong KongOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT01415479 | Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening | completed | N/A | 212 | Indiana UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00598156 | Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva(ACT) | completed | Phase 3 | 249 | Lund University HospitalOTHER | 2 | Apr 22, 2013 | clinicaltrials |
| NCT01834742 | Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects(OUT) | completed | Phase 1 | 161 | NorgineINDUSTRY | 1 | Apr 18, 2013 | clinicaltrials |
| NCT01831310 | Nutrition for Colorectal Cancer Patients and Neutrophil Functions | completed | Phase 4 | 36 | Kocaeli UniversityOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00005076 | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 110 | University of Alabama at BirminghamOTHER | 0 | Apr 12, 2013 | clinicaltrials |
| NCT00005094 | Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps | completed | Phase 3 | 1,170 | National Cancer Institute (NCI)NIH | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00199654 | Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III | completed | Phase 3 | 376 | University Hospital, LimogesOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00258232 | Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00369109 | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | completed | — | 60 | Barbara Ann Karmanos Cancer InstituteOTHER | 2 | Apr 8, 2013 | clinicaltrials |
| NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | completed | Phase 3 | 1,917 | SWOG Cancer Research NetworkNETWORK | 3 | Apr 5, 2013 | clinicaltrials |
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01324284 | Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy(Lubiprostone) | completed | Phase 3 | 442 | Asian Institute of Gastroenterology, IndiaOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00896896 | Immunoreactivity to Cetuximab in Cancer Patients | completed | — | 538 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Apr 2, 2013 | clinicaltrials |
| NCT00097578 | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma | completed | — | 1,953 | Genentech, Inc.INDUSTRY | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 18, 2013source: clinicaltrials